Oral Presentation
Infant lung disease: physiology, assessment and novel therapies
Chairs
C. Roehr
Oxford (Oxfordshire)
(United Kingdom)
10:45
Late Breaking Abstract - Nasal high-flow therapy (nHFT) as primary respiratory support for preterm infants without use of nasal continuous positive airways pressure (nCPAP).
S. Zivanovic(London, United Kingdom)
COI
1
11:00
Postnatal steroids in preterm lambs: long term impact on lung mechanics and respiratory control
C. Veneroni(Milano (MI), Italy)
COI
2
11:15
Maternal smoking in pregnancy increases the duration of home oxygen therapy in infants with bronchopulmonary dysplasia
A. Prayle(Nottingham (Nottinghamshire), United Kingdom)
COI
3
11:30
Serum albumin as a mortality predictor in the Pediatric Intensive Care Unit (PICU)
Y. Kim(Seoul, Republic of Korea)
COI
4
11:45
Effect of maturity and infection on the rate of relaxation of the respiratory muscles in ventilated, newborn infants
T. Dassios(London, United Kingdom)
COI
5
12:00
Recombinant human (rh)IGF-1/rhIGFBP-3 for prevention of bronchopulmonary dysplasia.
C. Poggi(Firenze (FI), Italy)
COI
6
12:15
Shift in very preterm infants with oxyhaemoglobin saturation >94% in room air
B. Stoecklin(Basel, Switzerland)
COI
7
12:30
Longitudinal lung function following very premature birth
C. Harris(London, United Kingdom)
COI
8
. . .
